Open access
Sep 2026
Dual-antigen AdV5 vaccines against Crimean-Congo hemorrhagic fever virus induce superior humoral and Th1-biased cellular immunity
Immunization with adenovirus serotype 5 (AdV5) vectors expressing CCHFV antigens elicited potent humoral and cellular immune responses, conferring 100% protection against lethal viral challenge across the majority of evaluated formulations.
A. Hanifehnezhad, S. Oztop, E. Tavukçuoğlu et al.
· Scientific Reports · 1 citation